Clinical Trial: Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586787) titled 'Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy' on May 07.

Brief Summary: The goal of this clinical trial is to learn whether early microincision vitrectomy surgery (MIVS) can improve retinal neovascularization outcomes compared to standard pan-retinal photocoagulation (PRP) in patients with early proliferative diabetic retinopathy (PDR). It will also evaluate the safety and functional outcomes of early surgical intervention in this population.

The main questions it aims to answer are:

Does early MIVS increase the proportion of eyes achieving complete regression of retinal neovascularization at 12 months? Does ...